CordenPharma to Acquire Peptisyntha SA from Solvay - - BioPharm International

ADVERTISEMENT

CordenPharma to Acquire Peptisyntha SA from Solvay



International Chemical Investors Group (ICIG) and the Solvay Group have formed an agreement under which ICIG will acquire Peptisyntha SA, the Brussels-based custom manufacturer of peptides. Upon closing of the deal, expected later this fall, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptide manufacturing.

Although the US sister company Peptisyntha Inc., located in Torrance, California, is not part of the transaction, certain customer relationships will be assumed by Peptisyntha in Brussels.

Source: CordenPharma

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines

Click here